Canine respiratory coronavirus for treatment and protection against bacterial infections
AssigneeZoetis Services LLC
InventorsShelly Lynn Shields, Omar Yousif Abdelmagid
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions, combinations, and methods comprising Canine Respiratory Coronavirus (CRCoV), which are effective in treating or preventing respiratory infections associated secondary pathogens, such as Bordetella bronchiseptica, in animals.
Claims6
A method of treating a respiratory infection in a dog in need thereof, comprising administering to the dog in need thereof a composition comprising an antigenic component, the antigenic component consisting of canine respiratory coronavirus (CRCoV) and one or more of canine parainfluenza virus (CPIV), canine influenza virus (CIV), canine distemper virus (CDV), canine parvovirus (CPV), enteric canine coronavirus (CCV), canine adenovirus, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae, Leptospira pomona, Leptospira bratislava, canine herpesvirus, canine pneumovirus, Leishmania organisms, a Borrelia species, Mycoplasma species, rabies, and Ehrlichia canis and wherein further said respiratory infection is Canine Infectious Respiratory Disease (CIRD) caused by co-infection with CRCoV and B. bronchiseptica.
A method of treating a respiratory infection in a dog in need thereof, comprising administering to the dog in need thereof a composition comprising an antigenic component, wherein the antigenic component consists of CRCoV, and wherein further said respiratory infection is CIRD caused by co-infection with CRCoV and B. bronchiseptica.
Dependencies are inferred from the claim text.